Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03)
Phase 4
- Conditions
- Colorectal Cancer
- Registration Number
- JPRN-UMIN000011459
- Lead Sponsor
- Kyoto Prefectural University of Medicine Department of Surgery Division of Digestive Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 251
Inclusion Criteria
Not provided
Exclusion Criteria
1. Prior oxaliplatin therapy 2. Prior chemotherapy or radiotherapy for colorectal cancer 3. Brain metastasis or active multiple malignancy 4. Peripheral nerve disorder 5. A history of severe drug allergy 6. Active infectious disease 7. Significant mental illness 8. Following complications i) Uncontrolled diabetes ii) Uncontrolled hypertension iii) Interstitial pneumonia iv) Iintestinal tract paralysis or ileus v) Significant heart trouble 9. Inadequate for study enrollment by the physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation of a clinical response and a clinicopathologic factor.
- Secondary Outcome Measures
Name Time Method Correlation of Dose Intensity and Relapse Free Survival. Safety